{
  "hash": "fd6f0223241ae8eec166e0a2c30b7ebb",
  "result": {
    "engine": "knitr",
    "markdown": "---\ntitle: \"The Near-Future of Regulatory Submissions: Embracing Reproducibility, Open Source, and Interactivity\"\nauthor: \"Davide Garolini & Leena Khatri\"\neditor: source\nformat: \n  revealjs: \n    footer:  \"[Regulatory Submissions with NEST](https://melkiades.github.io/regulatory-submissions-rinpharma2024/)\"\n    preview-links: auto\n    logo: \"images/bottom_logo.png\"\n    theme: slides.scss\n    transition: fade\n    slide-number: true\n    chalkboard:\n      buttons: false\n    title-slide-attributes: \n      data-background-image: images/background_with_roche_logo.png\nexecute:\n  echo: true\n  output: asis\n  freeze: auto\ncache: true\n---\n# Introduction\n\n\n\n## Licensing\n\n<br>\n\nThis material is based on the original work from the {gtreg} workshop by Shannon Pileggi and Daniel Sjoberg, available [here](https://shannonpileggi.github.io/gtreg-workshop-rinpharma-2022/), and adapted under a [Creative Commons Attribution 4.0 International License](https://creativecommons.org/licenses/by/4.0/).\n\n## Instructors\n\n:::: {.columns}\n::: {.column width=\"50%\"}\n**Davide Garolini**\n\n![](images/Davide_Garolini-PH.png){width=\"40%\"}\n\n<!-- `<svg aria-hidden=\"true\" role=\"img\" viewBox=\"0 0 640 512\" style=\"height:1em;width:1.25em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:#606888;overflow:visible;position:relative;\"><path d=\"M579.8 267.7c56.5-56.5 56.5-148 0-204.5c-50-50-128.8-56.5-186.3-15.4l-1.6 1.1c-14.4 10.3-17.7 30.3-7.4 44.6s30.3 17.7 44.6 7.4l1.6-1.1c32.1-22.9 76-19.3 103.8 8.6c31.5 31.5 31.5 82.5 0 114L422.3 334.8c-31.5 31.5-82.5 31.5-114 0c-27.9-27.9-31.5-71.8-8.6-103.8l1.1-1.6c10.3-14.4 6.9-34.4-7.4-44.6s-34.4-6.9-44.6 7.4l-1.1 1.6C206.5 251.2 213 330 263 380c56.5 56.5 148 56.5 204.5 0L579.8 267.7zM60.2 244.3c-56.5 56.5-56.5 148 0 204.5c50 50 128.8 56.5 186.3 15.4l1.6-1.1c14.4-10.3 17.7-30.3 7.4-44.6s-30.3-17.7-44.6-7.4l-1.6 1.1c-32.1 22.9-76 19.3-103.8-8.6C74 372 74 321 105.5 289.5L217.7 177.2c31.5-31.5 82.5-31.5 114 0c27.9 27.9 31.5 71.8 8.6 103.9l-1.1 1.6c-10.3 14.4-6.9 34.4 7.4 44.6s34.4 6.9 44.6-7.4l1.1-1.6C433.5 260.8 427 182 377 132c-56.5-56.5-148-56.5-204.5 0L60.2 244.3z\"/></svg>`{=html} [a](https://www.a.com/) -->\n\n`<svg aria-hidden=\"true\" role=\"img\" viewBox=\"0 0 448 512\" style=\"height:1em;width:0.88em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:#606888;overflow:visible;position:relative;\"><path d=\"M433 179.11c0-97.2-63.71-125.7-63.71-125.7-62.52-28.7-228.56-28.4-290.48 0 0 0-63.72 28.5-63.72 125.7 0 115.7-6.6 259.4 105.63 289.1 40.51 10.7 75.32 13 103.33 11.4 50.81-2.8 79.32-18.1 79.32-18.1l-1.7-36.9s-36.31 11.4-77.12 10.1c-40.41-1.4-83-4.4-89.63-54a102.54 102.54 0 0 1-.9-13.9c85.63 20.9 158.65 9.1 178.75 6.7 56.12-6.7 105-41.3 111.23-72.9 9.8-49.8 9-121.5 9-121.5zm-75.12 125.2h-46.63v-114.2c0-49.7-64-51.6-64 6.9v62.5h-46.33V197c0-58.5-64-56.6-64-6.9v114.2H90.19c0-122.1-5.2-147.9 18.41-175 25.9-28.9 79.82-30.8 103.83 6.1l11.6 19.5 11.6-19.5c24.11-37.1 78.12-34.8 103.83-6.1 23.71 27.3 18.4 53 18.4 175z\"/></svg>`{=html} [\\@melkiades](https://mastodon.social/@melkiades)\n\n`<svg aria-hidden=\"true\" role=\"img\" viewBox=\"0 0 496 512\" style=\"height:1em;width:0.97em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:#606888;overflow:visible;position:relative;\"><path d=\"M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z\"/></svg>`{=html} [melkiades](https://github.com/melkiades/)\n\n`<svg aria-hidden=\"true\" role=\"img\" viewBox=\"0 0 448 512\" style=\"height:1em;width:0.88em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:#606888;overflow:visible;position:relative;\"><path d=\"M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3zM135.4 416H69V202.2h66.5V416zm-33.2-243c-21.3 0-38.5-17.3-38.5-38.5S80.9 96 102.2 96c21.2 0 38.5 17.3 38.5 38.5 0 21.3-17.2 38.5-38.5 38.5zm282.1 243h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9V416z\"/></svg>`{=html} [davidegarolini](https://www.linkedin.com/in/davidegarolini/)\n:::\n\n::: {.column width=\"50%\"}\n**Leena Khatri**\n\n![](images/profile_picture.png){width=\"40%\"}\n\n`<svg aria-hidden=\"true\" role=\"img\" viewBox=\"0 0 496 512\" style=\"height:1em;width:0.97em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:#606888;overflow:visible;position:relative;\"><path d=\"M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z\"/></svg>`{=html} [khatril](https://github.com/khatril)\n\n`<svg aria-hidden=\"true\" role=\"img\" viewBox=\"0 0 448 512\" style=\"height:1em;width:0.88em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:#606888;overflow:visible;position:relative;\"><path d=\"M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3zM135.4 416H69V202.2h66.5V416zm-33.2-243c-21.3 0-38.5-17.3-38.5-38.5S80.9 96 102.2 96c21.2 0 38.5 17.3 38.5 38.5 0 21.3-17.2 38.5-38.5 38.5zm282.1 243h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9V416z\"/></svg>`{=html} [leena-khatri-a8a364108](http://linkedin.com/in/leena-khatri-a8a364108)\n:::\n::::\n\n## Schedule\n\n| Time          | Activity                               |\n|:--------------|:---------------------------------------|\n| 09:00 - 09:20 | Why Change?                            |\n| 09:20 - 10:10 | Getting there (P1)                     |\n| 10:10 - 10:20 | *Break*                                |\n| 10:20 - 11:10 | Getting there (P2)                     |\n| 11:10 - 11:20 | What do we expect?                     |\n| 11:20 - 11:30 | Additional resources: Collaborate!     |\n\n<br>\n\nPlease add any questions to the public Zoom chat. These may be answered in the moment or addressed at the end depending on context.\n\n# Why change? From proprietary software to R\n\n## Main task: _reporting clinical trials_\n\n<br>\n<br>\n<br>\n\nPurpose of regulatory submissions is to show efficacy and safety of new drugs.\n\n. . .\n\n<br>\n\n- Deliver analysis reports, datasets, and software\n- Health Authorities (HA) need to be able to reproduce key results\n\n\n## Why migrate to R in Clinical Trials?\n_Benefits for all_\n\n<br>\n<br>\n\n::: incremental\n\n* **Cost Efficiency:** R is free, reducing software costs.\n\n* **Flexibility:** R offers greater customization and a vast package ecosystem.\n\n* **Community Support and Collaboration:** R has a large, active community driving rapid innovation.\n\n:::\n\n##\n![](images/community_support.png)\n\n::: footer\nFrom [R/Adoption Series: R and Shiny in Regulatory Submissions](https://www.youtube.com/watch?v=wKG8VyZg6V0)\n:::\n\n##\n\n![](images/rconsortium_companies_involved.png)\n\n::: footer\nFrom [R/Adoption Series: R and Shiny in Regulatory Submissions](https://www.youtube.com/watch?v=wKG8VyZg6V0)\n:::\n\n##\n\n:::: {.columns .v-center-container}\n::: {.column width=\"50%\"}\n![](images/pharmaverse.png)\n:::\n\n::: {.column width=\"50%\"}\n![](images/pharmaverse_companies_involved.png)\n:::\n::::\n\n::: footer\nFrom [https://pharmaverse.org/](https://pharmaverse.org/)\n:::\n\n## Why migrating to R in Clinical Trials?\n_What's in it for us_\n\n<br>\n\n::: incremental\n\n* **Talent Pool:** Growing number of professionals trained in R.\n* **Transparency:** R’s open-source nature ensures full transparency and reproducibility.\n* **Integration:** R easily integrates with modern data tools and platforms.\n* **R is a transversal skill:** other business units may benefit from R programmers.\n* **Scalability in complexity:** very novel methods can be readily applied to clinical trials growing in complexity.\n\n:::\n\n## Roche - Pioneering modernised solutions in R\n\n<br> <br>\n\n. . .\n\n2017 &nbsp;&nbsp;&rarr; **PoCs**\n\n{rtables}, {teal} for interactive work were launched and presented at RinPharma\n\n<br>\n\n. . .\n\n2021 &nbsp;&nbsp;&rarr; **Open-source**\n\n{rtables} made the first CRAN release, followed by open source of the codebase to kick off collaborations with other companies\n\n\n## Roche - Pioneering modernised solutions in R\n\n<br> <br>\n\n. . .\n\n2023 &nbsp;&nbsp;&rarr; **Adoption of tools and systems**\n\nValidated environment to deliver our vision of R in submissions\n\n<br>\n\n. . .\n\n2024 &nbsp;&nbsp;&rarr; **E2E submission in R**\n\n\n## [Roche's End-to-End R Journey to Submission ](https://www.youtube.com/watch?v=BlJNILSoZlM)\n\n![](images/01_E2E_submissions.png)\n\n#\n\n&rarr; **Regulatory Acceptance:** R is increasingly accepted by regulatory agencies.\n\n<br>\n\n. . .\n\n_Evolution or Revolution?_\n\n\n## \n\n![](images/01_Rconsortium_r_submission_wg_and_fda.png)\n\n::: footer\nFrom [R/Adoption Series: R and Shiny in Regulatory Submissions](https://www.youtube.com/watch?v=wKG8VyZg6V0)\n:::\n\n## \n\n\n![](images/01_example_table_pilot1.png)\n\n::: footer\nFrom [R/Adoption Series: R and Shiny in Regulatory Submissions](https://www.youtube.com/watch?v=wKG8VyZg6V0)\n:::\n\n## \n\n![](images/01_example_km_plot_pilot2.png)\n\n::: footer\nFrom [R/Adoption Series: R and Shiny in Regulatory Submissions](https://www.youtube.com/watch?v=wKG8VyZg6V0)\n:::\n\n##\n\n:::: {.columns .v-center-container}\n::: {.column width=\"80%\"}\n![](images/01_pilot2_usesTealRtables.png)\n:::\n\n::: {.column width=\"70%\"}\n![](images/01_pilot2_usesRtables.png)\n:::\n::::\n\n::: footer\nCheck [https://github.com/RConsortium/submissions-pilot2/](https://github.com/RConsortium/submissions-pilot2/)\n:::\n\n## Findings and issues from FDA\n\n<br>\n<br>\n\n1. Different versions (R and open-source changes fast!)\n2. Different OS (Linux and Windows)\n3. Interactive features and p-hacking\n\n. . .\n\n<br>\n\n1.-2.  Docker or WebAssembly (Pilot 4)\n3. Even if p-hacking is NOT technology dependent, the ease-of-use and tweaking binds interactive features to the exploratory world\n\n<br>\n\n::: footer\nFrom Hye Soo Cho, FDA, in [R/Adoption Series: R and Shiny in Regulatory Submissions](https://www.youtube.com/watch?v=wKG8VyZg6V0)\n:::\n\n## \n\n![](images/01_FDA_suggestions_for_r_submissions.png)\n\n::: footer\nFrom [R/Adoption Series: R and Shiny in Regulatory Submissions](https://www.youtube.com/watch?v=wKG8VyZg6V0)\n:::\n\n#\n\n**Reproducibility and validation** - CRAN and extensive CI/CD testing, precise documentation and versioning\n\n<br>\n\n. . .\n\n**Open-source** -  Collaboration and transparency accelerates industry towards standardization due to a wider adoption (faster submissions?)\n\n<br>\n\n. . .\n\n**Interactivity** - {teal} as exploratory tool, integrates standard TLF, enables novel findings, and fast reviewer responses\n\n\n## What is NEST\n_Accelerating Clinical Reporting_\n\n:::: {.columns .v-center-container}\n::: {.column width=\"30%\"}\n![](images/NEST.png)\n:::\n\n::: {.column width=\"50%\"}\n\nA collection of _open-sourced_ R packages, which enables _fast_ and _efficient_ insights generation under clinical research settings, for both _exploratory_ and _regulatory_ purposes.\n\n:::\n::::\n\n\n## Landscape of NEST Products\n_Working towards a complete solution for R-based insights delivery_\n\n<br>\n\n![](images/01_package_hierarchy_description.png)\n\n# Getting there!\n\n_From an humble data.frame to mesmerizing interactive tables!_\n\n## Preparation\n\n<br>\n\n**Recommended:** Enter the dedicated RStudio Cloud work space (with packages pre-installed) to complete Exercise 1. It may still be helpful to peek at the [exercises web page](https://melkiades.github.io/regulatory-submissions-rinpharma2024/exercises.html){target=\"_blank\"} to verify that your results match the desired output.\n\n<br>\n\n&rarr;  [R in Pharma RStudio Cloud work space](https://posit.cloud/spaces/562648/join?access_code=fDZ1hAmNReOf6JuvxQXcHXTZezAu1qs0vrnUfyXh){target=\"_blank\"}  &larr;\n\n<br>\n\n**Otherwise:** Use your personal computer and follow along the [exercises on the\nwebsite](https://melkiades.github.io/regulatory-submissions-rinpharma2024/exercises.html){target=\"_blank\"}. Challenge yourself not to peek at the code solutions until you have completed the exercise.\n\n \n## Exercise 1\n\n<br>\n<br>\n\nCreate a demographic table by using only {dplyr}. \n\n<br>\n\n* The data should have only age, gender, and treatment columns. \n* The table should include the mean and standard deviation of age, the count and percentage.\n\n\n```{=html}\n<div class=\"countdown\" id=\"timer_d297be92\" data-update-every=\"1\" tabindex=\"0\" style=\"right:0;bottom:0;font-size:1.5em;\">\n<div class=\"countdown-controls\"><button class=\"countdown-bump-down\">&minus;</button><button class=\"countdown-bump-up\">&plus;</button></div>\n<code class=\"countdown-time\"><span class=\"countdown-digits minutes\">05</span><span class=\"countdown-digits colon\">:</span><span class=\"countdown-digits seconds\">00</span></code>\n</div>\n```\n\n\n<!-- ::: {style=\"text-align: center; margin-top: 1em\"} -->\n<!-- [Matplotlib: Visualization with Python](https://matplotlib.org/){preview-link=\"true\" style=\"text-align: center\"} -->\n<!-- ::: -->\n\n# What do we expect?\n\n#\n\n**Short-Term Considerations:**\n\nThe migration process requires initial investment in terms of time, resources, and training. Existing workflows and scripts need to be rewritten or adapted, which can be a significant effort.\n\n. . .\n\n<br>\n\n**Long-Term Benefits:**\n\nThe long-term benefits of migrating to R include cost savings, increased flexibility, access to a broader talent pool, and staying ahead in terms of technological advancements. If regulatory bodies continue to increase acceptance of R, the case for migration becomes even stronger.\n\n\n## Additional resources\n_Where to find more on NEST_\n\n<br>\n\n. . .\n\n* Source code of all our packages: `<svg aria-hidden=\"true\" role=\"img\" viewBox=\"0 0 496 512\" style=\"height:1em;width:0.97em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:#606888;overflow:visible;position:relative;\"><path d=\"M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z\"/></svg>`{=html} [https://github.com/insightsengineering](https://github.com/insightsengineering)\n\n. . .\n\n<br>\n\n* NEST is part of [https://pharmaverse.org/](https://pharmaverse.org/)\n\n![](images/pharmaverse.png){width=20% height=20%}\n\n## Additional resources\n_Where to find more on NEST_\n\n<br>\n\n. . .\n\n* [Hands On Clinical Reporting Using R | Coursera](https://www.coursera.org/learn/hands-on-clinical-reporting-using-r)\n\n![](images/coursera.png)\n\n## Collaborate\n_How can I get involved?_\n\n. . .\n\n<br>\n<br>\n<br>\n\nNotice a 🐛 or an idea for enhancements💡?\n\n\n# **Get in touch!**\n\n#\n\n. . .\n\n`<svg aria-hidden=\"true\" role=\"img\" viewBox=\"0 0 496 512\" style=\"height:1em;width:0.97em;vertical-align:-0.125em;margin-left:auto;margin-right:auto;font-size:inherit;fill:#606888;overflow:visible;position:relative;\"><path d=\"M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z\"/></svg>`{=html} We encourage you to collaborate with us and contribute our code base can be found here: [https://github.com/insightsengineering](https://github.com/insightsengineering)\n\n. . .\n\n<br>\n\n🖮 You can get in touch with us on **slack** _#pharmaverse-pkgs_ channel [here](https://pharmaverse.slack.com/)\n\n. . .\n\n<br>\n\n📧 or contact Leena our product owner if you are interested in industry collaboration ([leena.khatri@roche.com](leena.khatri@roche.com))\n\n\n#\n\n🙏 [Click here to submit workshop feedback](https://www.smartsurvey.co.uk/s/J4A8FS/){target=\"_blank\"}\n\n\n",
    "supporting": [
      "index_files"
    ],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {
      "include-in-header": [
        "<link href=\"../site_libs/countdown-0.4.0/countdown.css\" rel=\"stylesheet\" />\n<script src=\"../site_libs/countdown-0.4.0/countdown.js\"></script>\n"
      ],
      "include-after-body": [
        "\n<script>\n  // htmlwidgets need to know to resize themselves when slides are shown/hidden.\n  // Fire the \"slideenter\" event (handled by htmlwidgets.js) when the current\n  // slide changes (different for each slide format).\n  (function () {\n    // dispatch for htmlwidgets\n    function fireSlideEnter() {\n      const event = window.document.createEvent(\"Event\");\n      event.initEvent(\"slideenter\", true, true);\n      window.document.dispatchEvent(event);\n    }\n\n    function fireSlideChanged(previousSlide, currentSlide) {\n      fireSlideEnter();\n\n      // dispatch for shiny\n      if (window.jQuery) {\n        if (previousSlide) {\n          window.jQuery(previousSlide).trigger(\"hidden\");\n        }\n        if (currentSlide) {\n          window.jQuery(currentSlide).trigger(\"shown\");\n        }\n      }\n    }\n\n    // hookup for slidy\n    if (window.w3c_slidy) {\n      window.w3c_slidy.add_observer(function (slide_num) {\n        // slide_num starts at position 1\n        fireSlideChanged(null, w3c_slidy.slides[slide_num - 1]);\n      });\n    }\n\n  })();\n</script>\n\n"
      ]
    },
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}